XML 67 R27.htm IDEA: XBRL DOCUMENT v3.25.0.1
Schedule II Valuation and Qualifying Accounts (Notes)
 12 Months Ended
Dec. 31, 2024
SEC Schedule, 12-09, Valuation and Qualifying Accounts [Abstract]  
SEC Schedule, 12-09, Schedule of Valuation and Qualifying Accounts Disclosure
(a) 1.Financial Statements
The following Consolidated Financial Statements are set forth in Part II, Item 8 of this report.
Report of Independent Registered Public Accounting Firm
Consolidated Statements of Earnings for 2024, 2023 and 2022
Consolidated Statements of Comprehensive Income for 2024, 2023 and 2022
Consolidated Balance Sheets on 2024 and 2023
Consolidated Statements of Shareholders’ Equity for 2024, 2023 and 2022
Consolidated Statements of Cash Flows for 2024, 2023 and 2022
Notes to Consolidated Financial Statements
(a) 2.Financial Statement Schedules
The Consolidated Financial Statement schedule of Stryker Corporation and its subsidiaries is:
SCHEDULE II - VALUATION AND QUALIFYING ACCOUNTS
  AdditionsDeductions 
DescriptionBalance at
Beginning
of Period		Charged to
Costs &
Expenses		Uncollectible Amounts Written Off, Net of RecoveriesEffect of Changes in Foreign Currency Exchange RatesBalance
at End
of Period
DEDUCTED FROM ASSET ACCOUNTS
Allowance for Doubtful Accounts:
Year ended December 31, 2024
$182 $69 $36 $2 $213 
Year ended December 31, 2023
$154 $69 $40 $1 $182 
Year ended December 31, 2022
$167 $41 $52 $2 $154 
All other schedules for which provision is made in the applicable accounting regulation of the United States Securities and Exchange Commission are not required under the related instructions or are inapplicable and, therefore, have been omitted.
(a) 3.Exhibits